drugset / Trial / NCT07383571
Oral Hyoscine vs Lidocaine-Prilocaine Spray vs Placebo for HSG Pain Relief
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This single-centre, three-arm, randomised, double-blind, double-dummy, placebo-controlled trial evaluated the efficacy and safety of oral hyoscine butylbromide, topical lidocaine-prilocaine spray and placebo for reducing pain during hysterosalpingography in women with primary infertility. Pain was self-rated using an 11-point numerical rating scale at predefined procedural time points, including cervical instrumentation and uterine filling.
Timeline
- Start
- 2025-10-03
- Primary completion
- 2026-04-01
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyoscine butylbromide | Unknown | 20 mg | Oral |
| Comparator | Lidocaine | Other / unclassified | 15 % | Topical |
| Comparator | prilocaine | Small molecule | 5 % | Topical |
Indications
No indication recorded.